BOSTON ( TheStreet) -- IBM ( IBM) selected a Boston-area startup that aims to rid the world of counterfeit medicine in a business-idea competition.

Sproxil won the Boston installment of IBM SmartCamp, a competition that provides networking opportunities to a select group of technology startups.

To qualify for SmartCamp, a startup must be younger than 3 years old with maximum annual sales of less than $1 million. Throughout the year, IBM will be running one-day SmartCamp programs in Paris, Tel Aviv, Silicon Valley, Boston, Stockholm and London.

At the end of each event, Big Blue chooses a company from each city to attend SmartCamp week in Dublin (Nov. 15), where the worldwide winner will be named. There's no direct cash prize -- the grand prize is a few months of mentorship from IBM officials -- but of the five startups that made it to the finals last year, four received significant funding offers from angel investors.

Sproxil uses cell-phone-based authentication technology to help prevent counterfeit drugs in developing countries. Consumers scratch off a security code on the medicine bottle -- like with a lottery ticket -- and then they text the code to Sproxil from their cell phones. If the code is legitimate, consumers immediately receive a confirmation message. The technology will work with any phone that supports texting.

Drug counterfeiting is, by some estimates, a problem that generates tens of billions of dollars annually for criminals. Recent counterfeiting schemes resulted in sales of fake and ineffective versions of the Genentech ( DNA) anti-obesity drug Xenical and the anti-malarial drug Metakelfin, according to the World Health Organization.

-- Reported by Carmen Nobel in Boston.

If you liked this article you might like

Five-Day Winning Streak in Stocks Expected to Continue

Five-Day Winning Streak in Stocks Expected to Continue

Bitcoin Today: Prices Burst Through $10,000 as Traders Mitigate Stark Warnings

Bitcoin Today: Prices Burst Through $10,000 as Traders Mitigate Stark Warnings

Apple Stock Is Being Bought by Warren Buffett; Should You Buy It?

Apple Stock Is Being Bought by Warren Buffett; Should You Buy It?

Apple Could Get to Zero Net Cash This Way, Says UBS

Apple Could Get to Zero Net Cash This Way, Says UBS

Why You Cannot Rule Out a Much Deeper Stock Market Correction

Why You Cannot Rule Out a Much Deeper Stock Market Correction